Showing 1 - 10 of 2,259
This report provides an analysis of patents covering medicines in trials to treat COVID-19. The aim of the report is to support national patent offices and interested parties in developing countries with information that can serve as guidance for the examination of the claims contained in...
Persistent link: https://www.econbiz.de/10013194325
In developing countries, public sector health facilities frequently run out of essential medicines (“stockouts”). I test whether anti-malarial drug stockouts affect prices, quality, and overall access to anti-malarial drugs in private sector outlets in Uganda. I combine data from four...
Persistent link: https://www.econbiz.de/10013323674
Despite multilateral commitments and political statements of solidarity and cooperation to guarantee the availability and access to COVID-19 vaccines (and other relevant technologies for control and treatment), the scenario after the beginning of vaccination is marked by the deepening of vaccine...
Persistent link: https://www.econbiz.de/10012496070
Persistent link: https://www.econbiz.de/10012596763
Persistent link: https://www.econbiz.de/10012433565
Persistent link: https://www.econbiz.de/10012433647
Persistent link: https://www.econbiz.de/10012433673
Persistent link: https://www.econbiz.de/10012433890
This paper aims to analyze the interfaces between Brazilian Competition Law and the issue of access to medicines, with a special focus on abuse of industrial property rights and related exclusionary and exploitative effects. The paper analyzes the case law of Brazilian Administrative Council for...
Persistent link: https://www.econbiz.de/10013365665
Persistent link: https://www.econbiz.de/10014461499